Storage and handling
Other Information Protect the product in this container from excessive heat and direct sun
No7 Beautiful Skin Oil Free Skin Protector All Skin Types SPF 25
- Manufacturer
- Boots Retail USA Inc | The Boots Company PLC | BCM Ltd
- Effective date
- 2012-05-02
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-05-31 22:31:39
Label at a glance#
ProductNo7 Beautiful Skin Oil Free Skin Protector All Skin Types SPF 25
Active ingredientAvobenzone, Octisalate, Octocrylene
Label structure17 sections
Contacts and useful links#
Websitewww.boots.com
www.boots.com/no7
www.boots.com/no7Label contents#
Full prescribing information#
INACTIVE INGREDIENT SECTION
Inactive Ingredients
Aqua (water), C12-15 alkyl benzoate, Glycerin, Cetearyl glucoside, Dimethicone, Tribehenin, Aluminum starch octenylsuccinate, Ammonium acryloyldimethyltaurate/VP copolymer, Phenoxyethanol, Cetearyl alcohol, Tocopheryl acetate, Potassium cetyl phosphate, Methylparaben, Xanthan gum, Ethylparaben, Tetrasodium EDTA, T-butyl alcohol, Citric acid, Simethicone
OTC - QUESTIONS SECTION
USA: Questions? 1-866-75-BOOTS
The Boots Company PLC Nottingham England NG2 3AA
Dist. by Boots Retail USA Inc. Norwalk CT 06851 USA
Made in the UK
DESCRIPTION SECTION
No7 Beautiful Skin.
Created to provide tailored skin nutrition for healthy looking, bright and beautiful skin.
Protect your skin from the damaging effects of the sun everyday with this lightweight and oil free formulated sunscreen skin protector that melts into your skin without blocking pores.
Created with anti-oxidant Vitamin E to help protect against damaging free radicals and mattifying ingredients to help keep skin shine free. It's non-greasy texture won't block pores so your skin will stay feeling fresh all day long.
Hypo-allergenic: Because all skin can have sensitive moments all our products are hypo-allergenic, using ingredients we know and trust.
Created to provide tailored skin nutrition for healthy looking, bright and beautiful skin.
Protect your skin from the damaging effects of the sun everyday with this lightweight and oil free formulated sunscreen skin protector that melts into your skin without blocking pores.
Created with anti-oxidant Vitamin E to help protect against damaging free radicals and mattifying ingredients to help keep skin shine free. It's non-greasy texture won't block pores so your skin will stay feeling fresh all day long.
Hypo-allergenic: Because all skin can have sensitive moments all our products are hypo-allergenic, using ingredients we know and trust.
INDICATIONS & USAGE SECTION
For Best Results: Smooth into your face and neck after cleansing every
morning or apply over your moisturizer for extra SPF protection.
OTC - ACTIVE INGREDIENT SECTION
Active Ingredients
Avobenzone 3%, Octisalate 3.5%, Octocrylene 7.5%
Purpose
Sunscreen
OTC - PURPOSE SECTION
Uses
Helps prevent sunburn
WARNINGS AND PRECAUTIONS SECTION
Warnings
For external use only
Do not use on damaged or broken skin
When using this product keep out of eyes. Rinse with water to remove.
OTC - ASK DOCTOR SECTION
Stop use and ask a doctor if rash occurs
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
If swallowed, get medical help or contact a Poison Control Center right away
INSTRUCTIONS FOR USE SECTION
Directions
Apply liberally 15 minutes before sun exposure
Use a water resistant sunscreen if swimming or sweating
Reapply at least every 2 hours
Children under 6 months of age: ask a doctor
Sun Protection Measures. Spending time in the sun increases your risk of skin cancer and early skin aging. To decrease this risk, regularly use a sunscreen with a broad spectrum SPF value of 15 or higher and other sun protection measures including:
limit time in the sun, especially from 10a.m. - 2p.m.
wear long-sleeved shirts, pants, hat and sunglasses
STORAGE AND HANDLING SECTION
Other Information
Protect the product in this container from excessive heat and direct sun
DESCRIPTION SECTION
TUBE TEXT
No7 Beautiful Skin.
Created to provide tailored skin protection for healthy looking, bright and beautiful skin.
Protect your skin from the damaging effects of the sun everyday with this lightweight and oil free formulated sunscreen skin protector, that melts into your skin without blocking pores.
Created with anti-oxidant Vitamin E to help protect against damaging free radicals and mattifying ingredients to help keep skin shine free. It's non-greasy texture won't block pores so your skin will stay feeling fresh all day long.
For Best Results: Smooth into your face and neck after cleansing every morning or apply over your moisturizer for extra SPF protection.
WARNINGS SECTION
TUBE TEXT
Warning: Avoid contact with eyes. If product gets into the eyes rinse well with water immediately.
OTC - ACTIVE INGREDIENT SECTION
TUBE TEXT
Active ingredients: Octocrylene 7.5%, Octisalate 3.5%, Avobenzone 3%.
INFORMATION FOR PATIENTS SECTION
TUBE TEXT
The Boots Company PLC
Nottingham England NG2 3AA
Dist. in the USA by Boots Retail USA Inc.
Norwalk CT 06851 USA
Made in the UK
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
No7 Beautiful Skin
Oil Free Skin Protector
All Skin Types
Sunscreen Broad Spectrum SPF 25
50ml 1.6 US Fl.Oz.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
No7 Beautiful Skin
Oil Free Skin Protector
All Skin Types
Sunscreen Broad Spectrum SPF 25
Hypo-allergenic
50ml 1.6 US Fl.Oz.
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 68472-108-01 | 2019-11-13 | C162847 | 48780-1 | 97449f38-c9ce-f6ea-e053-dbdaa90aa703 | Carton and tube labelling |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 68472-108-01 | No7 Beautiful Skin Oil Free Skin Protector All Skin Types SPF 25 | 1 in 1 CARTON | CREAM | 1 | 1 | |
| 68472-108-01 | No7 Beautiful Skin Oil Free Skin Protector All Skin Types SPF 25 | 50 mL in 1 TUBE | CREAM | 50 | 1 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 68472-108 | NO7 BEAUTIFUL SKIN OIL FREE SKIN PROTECTOR ALL SKIN TYPES SPF 25 (AVOBENZONE, OCTISALATE AND OCTOCRYLENE) CREAM [BOOTS RETAIL USA INC] | 1 | Legacy NDC, 2 package rows | 20120504_29f7f802-d473-46e0-9eda-d9b2bc2d6dd5.zip |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Avobenzone | ACTIVE INGREDIENT | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE INGREDIENT | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE INGREDIENT | 5A68WGF6WM | 1 | |
| Avobenzone | ACTIVE MOIETY | G63QQF2NOX | 1 | |
| Octisalate | ACTIVE MOIETY | 4X49Y0596W | 1 | |
| Octocrylene | ACTIVE MOIETY | 5A68WGF6WM | 1 | |
| .ALPHA.-TOCOPHEROL ACETATE | INACTIVE INGREDIENT | 9E8X80D2L0 | 1 | |
| ALKYL (C12-15) BENZOATE | INACTIVE INGREDIENT | A9EJ3J61HQ | 1 | |
| ALUMINUM STARCH OCTENYLSUCCINATE | INACTIVE INGREDIENT | I9PJ0O6294 | 1 | |
| AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER | INACTIVE INGREDIENT | W59H9296ZG | 1 | |
| CETEARYL GLUCOSIDE | INACTIVE INGREDIENT | 09FUA47KNA | 1 | |
| CETOSTEARYL ALCOHOL | INACTIVE INGREDIENT | 2DMT128M1S | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| Dimethicone | INACTIVE INGREDIENT | 92RU3N3Y1O | 1 | |
| EDETATE SODIUM | INACTIVE INGREDIENT | MP1J8420LU | 1 | |
| ETHYLPARABEN | INACTIVE INGREDIENT | 14255EXE39 | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | 1 | |
| PHENOXYETHANOL | INACTIVE INGREDIENT | HIE492ZZ3T | 1 | |
| POTASSIUM CETYL PHOSPHATE | INACTIVE INGREDIENT | 03KCY6P7UT | 1 | |
| TERT-BUTYL ALCOHOL | INACTIVE INGREDIENT | MD83SFE959 | 1 | |
| TRIBEHENIN | INACTIVE INGREDIENT | 8OC9U7TQZ0 | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 | |
| XANTHAN GUM | INACTIVE INGREDIENT | TTV12P4NEE | 1 |
Products#
Every source-derived product name is available through these pages.
- No7 Beautiful Skin Oil Free Skin Protector All Skin Types SPF 25
- Avobenzone, Octisalate and Octocrylene
- Avobenzone
- Octisalate
- Octocrylene
- Water
- ALKYL (C12-15) BENZOATE
- GLYCERIN
- CETEARYL GLUCOSIDE
- Dimethicone
- TRIBEHENIN
- ALUMINUM STARCH OCTENYLSUCCINATE
- AMMONIUM ACRYLOYLDIMETHYLTAURATE/VP COPOLYMER
- PHENOXYETHANOL
- CETOSTEARYL ALCOHOL
- .ALPHA.-TOCOPHEROL ACETATE
- POTASSIUM CETYL PHOSPHATE
- METHYLPARABEN
- XANTHAN GUM
- ETHYLPARABEN
- EDETATE SODIUM
- TERT-BUTYL ALCOHOL
- CITRIC ACID MONOHYDRATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 68472-108 | 68472-108-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY, METERED / NASAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / ORAL | 346 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / AURICULAR (OTIC) | 63.64 %w/v | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | DROPS / OPHTHALMIC | 0.01 %w/w | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | POWDER, FOR SOLUTION / ORAL | 13 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRALESIONAL | 0.15 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION/ DROPS / ORAL | 750 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / SUBCUTANEOUS | 0.16 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CLOTH / TOPICAL | 0.05 mg/mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / SUBCUTANEOUS | 28 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SUSPENSION / AURICULAR (OTIC) | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | LIQUID / ORAL | 2400 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAPLEURAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | AEROSOL, FOAM / RECTAL | 7 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE / ORAL | 3822 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / OPHTHALMIC | 0.88 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INTRAVENOUS | 95 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | PASTE / ORAL | 1050 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPONGE / TOPICAL | 2 %w/w | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | POWDER, FOR SUSPENSION / ORAL | 75 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | LIQUID / ORAL | 162 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING / ORAL | 0.15 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / TOPICAL | 216 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| EDETATE SODIUM | EDETATE SODIUM | MP1J8420LU | SOLUTION / OPHTHALMIC | 0.1 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | ELIXIR / ORAL | 5621 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAOCULAR | 1 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | AEROSOL, FOAM / TOPICAL | 0.27 %w/w | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | GRANULE, FOR SOLUTION / ORAL | 14 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYRUP / ORAL | 722 mg/5ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOAP / TOPICAL | 0.5 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CONCENTRATE / ORAL | 1800 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SOLUTION / OPHTHALMIC | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / RESPIRATORY (INHALATION) | 8 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / PARENTERAL | 18 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | INJECTION / INFILTRATION | 80 mg | ||
| ETHYLPARABEN | ETHYLPARABEN | 14255EXE39 | SOLUTION / ORAL | 14 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | GRANULE, FOR SUSPENSION / ORAL | 113 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, COATED / ORAL | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TOPICAL | 500 mg | ||
| .ALPHA.-TOCOPHEROL ACETATE | .ALPHA.-TOCOPHEROL ACETATE | 9E8X80D2L0 | FILM / BUCCAL | 0.09 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRABURSAL | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | FILM, EXTENDED RELEASE / BUCCAL | 34 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LIQUID / ORAL | 114 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| PHENOXYETHANOL | PHENOXYETHANOL | HIE492ZZ3T | CREAM / TOPICAL | 57 mg | ||
| METHYLPARABEN | METHYLPARABEN | A2I8C7HI9T | SYSTEM / TOPICAL | 42 mg | ||
| XANTHAN GUM | XANTHAN GUM | TTV12P4NEE | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 36 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 6c38b673-07f7-43a7-974e-ec172a0c7e85 | 29f7f802-d473-46e0-9eda-d9b2bc2d6dd5 | 2012-05-02 | Warnings | 6c38b673-07f7-43a7-974e-ec172a0c7e85 29f7f802-d473-46e0-9eda-d9b2bc2d6dd5 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.